knowledge -WSS

knowledge

author：comprehensive 2025-10-03 00:22:28 - browse：2974

The Food and Drug Administration is poised to tell drug and medical device makers how to better include people of color in the clinical trials that test whether products work and are safe, an agency official said Wednesday. Those guidelines are five months late.

To ensure that drugs work for everyone, they must be tested on a representative sample of people. But researchers have found that many clinical trials exclude the people of color who are often most affected by the diseases that drugs treat.

To help fix that problem, Congress passed a law requiring companies to give the FDA their plans for diversifying clinical trials. As part of that process, the agency was expected to issue guidance by the end of last year.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： The response to Covid

explore

WSS

Faced with fears of OxyContin misuse, sales reps touted its safety

Severe heat forecast: Where scorching temperatures will persist over the next week

Statins reduce cardiovascular risk in people living with HIV

Severe heat forecast: Where scorching temperatures will persist over the next week

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

PrEP can help anyone prevent HIV. Why do so few people take it?

hotspot

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

focus

Alkermes shareholders re

What Henrietta Lacks's story taught me about my role as a doctor

Novavax promises a turnaround & Lilly roils the obesity market

Novo acquires Inversago for up to $1 billion

As demand for Covid shots wanes, Moderna seeks its next success

What Henrietta Lacks's story taught me about my role as a doctor

George Santos makes 1st court appearance after pleading not guilty to 13 counts

4 missing after record

How to save PrEP access — and even expand it

Statins reduce cardiovascular risk in people living with HIV

explore

Thousands protest mob assault of women who were paraded naked in remote Indian border state

Statins reduce cardiovascular risk in people living with HIV

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Novo acquires Inversago for up to $1 billion

Transgender women dream of pregnancy via uterus transplants

Some of the ways extreme heat will change life as we know it

hotspot

explore

focus

entertainment